Literature DB >> 23370976

Dynamic changes of Jab1 and p27kip1 expression in injured rat sciatic nerve.

Xinghai Cheng1, Zhengming Zhou, Guangfei Xu, Jing Zhao, Hao Wu, Long Long, Hai Wen, Xingxing Gu, Youhua Wang.   

Abstract

Jun activation domain-binding protein (Jab1) is a multifunctional protein that participates in affecting signaling pathway, controlling cell proliferation and apoptosis, and regulating genomic instability and DNA repair, and acts as a key subunit of COP9 signalosome. p27kip1, a member of the Cip/Kip family of cyclin-dependent kinase inhibitors, was shown to inhibit the enzymatic activity of cyclin-CDK complexes, resulting in cell-cycle arrest at G1. Recent studies have shown that Jab1 directly binds to p27kip1 and induces nuclear export and subsequent degradation in a variety of human cancers, while the association and function of Jab1 and p27kip1 in nervous system lesion and regeneration remain unclear. Here, we performed a sciatic nerve injury model in adult rats and studied the dynamic changes of Jab1 and p27kip1 expression by Western blot. Sciatic nerve crush (SNC) resulted in a significant upregulation of Jab1 and a downregulation of p27kip1. Besides, we observed that Jab1 was expressed widely in Schwann cells (SCs) and had few co-localization in axons by double immunofluorescence staining. In addition, the peak expression of Jab1 was parallel with proliferating cell nuclear antigen (PCNA), and numerous SCs expressing Jab1 were PCNA-positive. Results obtained by co-immunoprecipitation and double labeling further showed their interaction in the sciatic nerve. Thus, these results suggested that Jab1 and p27kip1 may be involved in the pathophysiology of sciatic nerve after SNC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370976     DOI: 10.1007/s12031-013-9969-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  48 in total

Review 1.  Molecular mechanisms of cellular interactions in peripheral nerve regeneration.

Authors:  P Küry; G Stoll; H W Müller
Journal:  Curr Opin Neurol       Date:  2001-10       Impact factor: 5.710

Review 2.  COP9 signalosome revisited: a novel mediator of protein degradation.

Authors:  C Schwechheimer; X W Deng
Journal:  Trends Cell Biol       Date:  2001-10       Impact factor: 20.808

3.  Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.

Authors:  Qing Chen; Weilin Xie; Deborah J Kuhn; Peter M Voorhees; Antonia Lopez-Girona; Derek Mendy; Laura G Corral; Veronique Plantevin Krenitsky; Weiming Xu; Laure Moutouh-de Parseval; David R Webb; Frank Mercurio; Keiichi I Nakayama; Keiko Nakayama; Robert Z Orlowski
Journal:  Blood       Date:  2008-02-27       Impact factor: 22.113

4.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.

Authors:  K Tomoda; Y Kubota; J Kato
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

5.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.

Authors:  R Kleemann; A Hausser; G Geiger; R Mischke; A Burger-Kentischer; O Flieger; F J Johannes; T Roger; T Calandra; A Kapurniotu; M Grell; D Finkelmeier; H Brunner; J Bernhagen
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

6.  Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.

Authors:  Chae Young Hwang; Yeung Sook Ryu; Mi-Sun Chung; Kwang Dong Kim; Sung Sup Park; Suhn-Kee Chae; Ho Zoon Chae; Ki-Sun Kwon
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

7.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

Review 8.  The COP9 signalosome.

Authors:  Ning Wei; Xing Wang Deng
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

9.  Arabidopsis homologs of a c-Jun coactivator are present both in monomeric form and in the COP9 complex, and their abundance is differentially affected by the pleiotropic cop/det/fus mutations.

Authors:  S F Kwok; R Solano; T Tsuge; D A Chamovitz; J R Ecker; M Matsui; X W Deng
Journal:  Plant Cell       Date:  1998-11       Impact factor: 11.277

10.  Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity.

Authors:  E Bianchi; S Denti; A Granata; G Bossi; J Geginat; A Villa; L Rogge; R Pardi
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

View more
  5 in total

1.  Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy.

Authors:  Lalit P Singh
Journal:  J Clin Exp Ophthalmol       Date:  2013-08-05

2.  SCY1-Like 1-Binding Protein 1 (SCYL1BP1) Suppressed Sciatic Nerve Regeneration by Enhancing the RhoA Pathway.

Authors:  Weidong Zhang; Yonghua Liu; Xudong Zhu; Yi Cao; Yang Liu; Xingxing Mao; Huiguang Yang; Zhengming Zhou; Youhua Wang; Aiguo Shen
Journal:  Mol Neurobiol       Date:  2015-11-16       Impact factor: 5.590

3.  JAB1 is Involved in Neuropathic Pain by Regulating JNK and NF-κB Activation After Chronic Constriction Injury.

Authors:  Yan Chen; Xiangdong Chen; Jiang Yu; Xingguo Xu; Xiaojia Wei; Xiaoling Gu; Chun Liu; Dongmei Zhang; Zhongling Xu
Journal:  Neurochem Res       Date:  2015-12-23       Impact factor: 3.996

4.  Upregulation of PRDM5 Is Associated with Astrocyte Proliferation and Neuronal Apoptosis Caused by Lipopolysaccharide.

Authors:  Yu Zhang; Xiaojuan Liu; Huaqing Xue; Xiaorong Liu; Aihua Dai; Yan Song; Kaifu Ke; Maohong Cao
Journal:  J Mol Neurosci       Date:  2016-04-13       Impact factor: 3.444

5.  Jab1 regulates Schwann cell proliferation and axonal sorting through p27.

Authors:  Emanuela Porrello; Cristina Rivellini; Giorgia Dina; Daniela Triolo; Ubaldo Del Carro; Daniela Ungaro; Martina Panattoni; Maria Laura Feltri; Lawrence Wrabetz; Ruggero Pardi; Angelo Quattrini; Stefano Carlo Previtali
Journal:  J Exp Med       Date:  2013-12-16       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.